Changes in Hong Kong stocks | Tianxing Healthcare (01609) rose more than 7% in the afternoon, and the company is expected to enter Hong Kong Stock Connect next month to officially buy back shares after the interim report

The Zhitong Finance App learned that Tianxing Healthcare (01609) rose more than 7% in the afternoon. As of press release, it had risen 7.07% to HK$149.9, with a turnover of HK$30.151 million.

According to the news, Star Medical announced that it has been selected by Hang Seng Index Co., Ltd. and will be included as a constituent stock of the Hang Seng Composite Index, effective September 7. After being included as a constituent stock of the Hang Seng Composite Index, the company's shares are expected to meet the criteria for Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect transactions. IPC is expected to further increase the company's attention and investability, and expand the coverage of potential investors.

According to Tianxing Medical's interim report, the company's revenue for the first half of the year was about RMB 163 million, up 21.6% year on year; adjusted net profit was about RMB 488.97 million, up 24.3% year on year. Overseas sales revenue during the period was approximately RMB 406.98 million, an increase of 70.6% over the same period in 2025. Overseas revenue increased as a share of total revenue to 24.9%. The company also announced that it plans to repurchase no more than 2.9 million H shares, accounting for about 5.29% of the total number of H shares issued by the company.